Dexamethasone Sodium Phosphate
- Product NDC
- 76045-212
- 11-digit product format
- 760450212
- Labeler code
- 76045
- Product ID
- 76045-212_6fd9ed0e-dddc-4e73-9442-49da54685f7b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DEXAMETHASONE SODIUM PHOSPHATE
- Dosage form
- INJECTION, EMULSION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA209192
- Marketing category
- ANDA
- Marketing start
- 2024-02-21
- Substance
- DEXAMETHASONE SODIUM PHOSPHATE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| AI9376Y64P | DEXAMETHASONE SODIUM PHOSPHATE | 2392-39-4 | DEXAMETHASONE SODIUM PHOSPHATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 76045-212-10 | 76045021210 | 24 BLISTER PACK in 1 CARTON (76045-212-10) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS (76045-212-00) | 24 blister pack | 2024-02-21 | No | No | Historical |